{"id":111600,"date":"2022-09-15T10:01:37","date_gmt":"2022-09-15T15:01:37","guid":{"rendered":"https:\/\/uwm.edu\/news\/?p=111600"},"modified":"2024-09-27T09:56:37","modified_gmt":"2024-09-27T14:56:37","slug":"uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds","status":"publish","type":"post","link":"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/","title":{"rendered":"UWM Research Foundation grants second patent license to Pantherics for novel drug compounds"},"content":{"rendered":"<p class=\"p1\"><span class=\"s1\">MILWAUKEE _ The University of Wisconsin-Milwaukee Research Foundation (<a href=\"https:\/\/uwmrf.org\/\"><span class=\"s2\">UWMRF<\/span><\/a>) has granted a second patent license to <a href=\"https:\/\/pantherics.com\/news\/\"><span class=\"s2\">Pantherics Incorporated<\/span><\/a> to support the company\u2019s commercial drug development programs.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">The latest license provides worldwide commercial rights to patents for novel drug compounds useful in the prevention and treatment of inflammatory diseases. The license was issued to Pantherics jointly with the following partners:<\/span><\/p>\n<ul>\n<li>Centre for Addiction and Mental Health (<a href=\"https:\/\/www.camh.ca\/500.html?aspxerrorpath=\/\"><span class=\"s2\">CAMH<\/span><\/a>) in Toronto<\/li>\n<li><a href=\"http:\/\/www.wisys.org\/\"><span class=\"s3\">WiSys<\/span><\/a><\/li>\n<li><a href=\"https:\/\/international.univ-tours.fr\/\"><span class=\"s3\">University of Tours<\/span><\/a><span class=\"s4\"> in France<\/span><\/li>\n<li><a href=\"https:\/\/www.bg.ac.rs\/en\/members\/faculties\/PHM.php\"><span class=\"s3\">University of Belgrade in Serbia-Faculty of Pharmacy<\/span><\/a><\/li>\n<\/ul>\n<p class=\"p1\"><span class=\"s1\">UWMRF previously granted a license to Pantherics covering a separate family of drug compounds that includes lead compound PI301, also being developed by the company for inflammatory disorders. That license was issued jointly with Columbia University.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">Formed in 2018, Pantherics is at the forefront of developing drugs that modulate\u00a0<\/span><span class=\"s1\">GABA<\/span><span class=\"s5\"><sub>A<\/sub><\/span><span class=\"s1\"> receptors (GABA<\/span><span class=\"s5\"><sub>A<\/sub><\/span><span class=\"s1\">R) to treat inflammatory and smooth muscle disorders. Their pioneering work offers an improved approach to treat inflammatory diseases with a focus on oral treatment of pulmonary (such as asthma and COPD), dermatologic and gastrointestinal disorders.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">The patents are based on research by the following individuals:<\/span><\/p>\n<ul>\n<li class=\"p1\"><span class=\"s1\">\u00a0<\/span><span class=\"s1\">Alexander Arnold: Pantherics\u2019 chief scientific officer and a founding scientist, professor of chemistry at UWM, and director of the <a href=\"https:\/\/uwm.edu\/drug-discovery\/\"><span class=\"s2\">Milwaukee Institute for Drug Discovery<\/span><\/a> (MIDD). The institute advances research and later-stage development of new drugs developed at UWM and collaborating institutions.<\/span><\/li>\n<li class=\"p1\"><span class=\"s1\">James Cook: Distinguished professor emeritus of chemistry and MIDD member.<\/span><\/li>\n<li class=\"p1\"><span class=\"s1\">Douglas Stafford: President of Pantherics and a founding scientist, and former MIDD director.<\/span><\/li>\n<\/ul>\n<p class=\"p1\"><span class=\"s1\">UWMRF has also supported their work through three catalyst seed grants that fund translational academic research.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">Pantherics has also received two recent awards through the UWMRF <a href=\"https:\/\/uwmrf.org\/bridge-grant-program\/\"><span class=\"s2\">Bridge Grant<\/span><\/a> program to support development of licensed technologies. The program bolsters efforts to commercialize innovative research developed at UWM and support new companies that improve the Wisconsin economy. The program leverages grant funding from the Wisconsin Economic Development Corporation <a href=\"https:\/\/wedc.org\/programs-and-resources\/capital-catalyst\/\"><span class=\"s2\">Capital Catalyst<\/span><\/a> program.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">\u201cOur partnership with UWMRF has provided essential resources for patenting, licensing and financial support for early-stage commercial drug development,\u201d Stafford said. \u201cThe UWM Research Foundation\u2019s support is essential to our work.\u201d<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">UWMRF is a nonprofit corporation that supports research, commercialization and innovation at UWM through a variety of programs, including patenting, licensing and startup support.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">\u201cThe Pantherics leadership team and their research collaborators are truly top-notch with deep experience in all stages of drug discovery and commercial development. PI301 is a great example of the impactful research taking place in MIDD labs,\u201d said Jessica Silvaggi, vice president of the UWMRF.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">For more information, please contact Silvaggi at <a href=\"mailto:research@uwmrf.org\"><span class=\"s2\">jessica@uwmrf.org<\/span><\/a> or Stafford at <a href=\"mailto:info@pantherics.com\"><span class=\"s2\">info@pantherics.com<\/span><\/a>.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MILWAUKEE _ The University of Wisconsin-Milwaukee Research Foundation (UWMRF) has granted a second patent license to Pantherics Incorporated to support the company\u2019s commercial drug development programs. The latest license provides worldwide commercial rights to patents for novel drug compounds useful in the prevention and treatment of inflammatory diseases. The license was issued to Pantherics jointly [&hellip;]<\/p>\n","protected":false},"author":40008,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","uwm_wg_additional_authors":[]},"categories":[202],"tags":[],"section":[],"display_categories":[],"related-coverage":[],"uwmnews-feed":[],"class_list":["post-111600","post","type-post","status-publish","format-standard","hentry","category-news-releases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>UWM Research Foundation grants second patent license to Pantherics for novel drug compounds<\/title>\n<meta name=\"description\" content=\"MILWAUKEE _ The University of Wisconsin-Milwaukee Research Foundation (UWMRF) has granted a second patent license to Pantherics Incorporated to support\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UWM Research Foundation grants second patent license to Pantherics for novel drug compounds\" \/>\n<meta property=\"og:description\" content=\"MILWAUKEE _ The University of Wisconsin-Milwaukee Research Foundation (UWMRF) has granted a second patent license to Pantherics Incorporated to support\" \/>\n<meta property=\"og:url\" content=\"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/\" \/>\n<meta property=\"og:site_name\" content=\"UWM REPORT\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-15T15:01:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-27T14:56:37+00:00\" \/>\n<meta name=\"author\" content=\"UWM News\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UWMNews\" \/>\n<meta name=\"twitter:site\" content=\"@UWMNews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"UWM News\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\\\/\"},\"author\":{\"name\":\"UWM News\",\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/#\\\/schema\\\/person\\\/d72440401ec36965989bb00390105686\"},\"headline\":\"UWM Research Foundation grants second patent license to Pantherics for novel drug compounds\",\"datePublished\":\"2022-09-15T15:01:37+00:00\",\"dateModified\":\"2024-09-27T14:56:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\\\/\"},\"wordCount\":443,\"publisher\":{\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/#organization\"},\"articleSection\":[\"News Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\\\/\",\"url\":\"https:\\\/\\\/uwm.edu\\\/news\\\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\\\/\",\"name\":\"UWM Research Foundation grants second patent license to Pantherics for novel drug compounds\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/#website\"},\"datePublished\":\"2022-09-15T15:01:37+00:00\",\"dateModified\":\"2024-09-27T14:56:37+00:00\",\"description\":\"MILWAUKEE _ The University of Wisconsin-Milwaukee Research Foundation (UWMRF) has granted a second patent license to Pantherics Incorporated to support\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/uwm.edu\\\/news\\\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/uwm.edu\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UWM Research Foundation grants second patent license to Pantherics for novel drug compounds\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/uwm.edu\\\/news\\\/\",\"name\":\"UWM REPORT\",\"description\":\"News from the University of Wisconsin - Milwaukee\",\"publisher\":{\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/uwm.edu\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/#organization\",\"name\":\"University of Wisconsin-Milwaukee\",\"url\":\"https:\\\/\\\/uwm.edu\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/uwm.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/41\\\/2017\\\/02\\\/uwm-seo-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/uwm.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/41\\\/2017\\\/02\\\/uwm-seo-logo.jpg\",\"width\":225,\"height\":224,\"caption\":\"University of Wisconsin-Milwaukee\"},\"image\":{\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/UWMNews\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/uwm.edu\\\/news\\\/#\\\/schema\\\/person\\\/d72440401ec36965989bb00390105686\",\"name\":\"UWM News\",\"url\":\"https:\\\/\\\/uwm.edu\\\/news\\\/author\\\/uwmnewsuwm-edu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"UWM Research Foundation grants second patent license to Pantherics for novel drug compounds","description":"MILWAUKEE _ The University of Wisconsin-Milwaukee Research Foundation (UWMRF) has granted a second patent license to Pantherics Incorporated to support","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/","og_locale":"en_US","og_type":"article","og_title":"UWM Research Foundation grants second patent license to Pantherics for novel drug compounds","og_description":"MILWAUKEE _ The University of Wisconsin-Milwaukee Research Foundation (UWMRF) has granted a second patent license to Pantherics Incorporated to support","og_url":"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/","og_site_name":"UWM REPORT","article_published_time":"2022-09-15T15:01:37+00:00","article_modified_time":"2024-09-27T14:56:37+00:00","author":"UWM News","twitter_card":"summary_large_image","twitter_creator":"@UWMNews","twitter_site":"@UWMNews","twitter_misc":{"Written by":"UWM News","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/#article","isPartOf":{"@id":"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/"},"author":{"name":"UWM News","@id":"https:\/\/uwm.edu\/news\/#\/schema\/person\/d72440401ec36965989bb00390105686"},"headline":"UWM Research Foundation grants second patent license to Pantherics for novel drug compounds","datePublished":"2022-09-15T15:01:37+00:00","dateModified":"2024-09-27T14:56:37+00:00","mainEntityOfPage":{"@id":"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/"},"wordCount":443,"publisher":{"@id":"https:\/\/uwm.edu\/news\/#organization"},"articleSection":["News Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/","url":"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/","name":"UWM Research Foundation grants second patent license to Pantherics for novel drug compounds","isPartOf":{"@id":"https:\/\/uwm.edu\/news\/#website"},"datePublished":"2022-09-15T15:01:37+00:00","dateModified":"2024-09-27T14:56:37+00:00","description":"MILWAUKEE _ The University of Wisconsin-Milwaukee Research Foundation (UWMRF) has granted a second patent license to Pantherics Incorporated to support","breadcrumb":{"@id":"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/uwm.edu\/news\/uwm-research-foundation-grants-second-patent-license-to-pantherics-for-novel-drug-compounds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/uwm.edu\/news\/"},{"@type":"ListItem","position":2,"name":"UWM Research Foundation grants second patent license to Pantherics for novel drug compounds"}]},{"@type":"WebSite","@id":"https:\/\/uwm.edu\/news\/#website","url":"https:\/\/uwm.edu\/news\/","name":"UWM REPORT","description":"News from the University of Wisconsin - Milwaukee","publisher":{"@id":"https:\/\/uwm.edu\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/uwm.edu\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/uwm.edu\/news\/#organization","name":"University of Wisconsin-Milwaukee","url":"https:\/\/uwm.edu\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/uwm.edu\/news\/#\/schema\/logo\/image\/","url":"https:\/\/uwm.edu\/news\/wp-content\/uploads\/sites\/41\/2017\/02\/uwm-seo-logo.jpg","contentUrl":"https:\/\/uwm.edu\/news\/wp-content\/uploads\/sites\/41\/2017\/02\/uwm-seo-logo.jpg","width":225,"height":224,"caption":"University of Wisconsin-Milwaukee"},"image":{"@id":"https:\/\/uwm.edu\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/UWMNews"]},{"@type":"Person","@id":"https:\/\/uwm.edu\/news\/#\/schema\/person\/d72440401ec36965989bb00390105686","name":"UWM News","url":"https:\/\/uwm.edu\/news\/author\/uwmnewsuwm-edu\/"}]}},"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-16 07:19:31","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/posts\/111600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/users\/40008"}],"replies":[{"embeddable":true,"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/comments?post=111600"}],"version-history":[{"count":3,"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/posts\/111600\/revisions"}],"predecessor-version":[{"id":111626,"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/posts\/111600\/revisions\/111626"}],"wp:attachment":[{"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/media?parent=111600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/categories?post=111600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/tags?post=111600"},{"taxonomy":"section","embeddable":true,"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/section?post=111600"},{"taxonomy":"display_categories","embeddable":true,"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/display_categories?post=111600"},{"taxonomy":"related-coverage","embeddable":true,"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/related-coverage?post=111600"},{"taxonomy":"uwmnews-feed","embeddable":true,"href":"https:\/\/uwm.edu\/news\/wp-json\/wp\/v2\/uwmnews-feed?post=111600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}